Recently, a paid subscriber asked me to do a piece about hormones versus peptides
Patients following plant-based diets, older adults, or those with a history of gastrointestinal surgery face higher risk
Introduction The GLP-1 receptor is where every obesity drug in the modern class begins
Phase 2 dose-finding study in patients with gout using SEL-212, a novel PEGylated uricase (SEL-037) combined with tolerogenic nanoparticles (SEL-110)
Maybe there is wording difference with micro-dosing, but there are published data on "lower" dosing, like: - Seier et al., 2025, Treat to Target in Weight Management with Semaglutide - P et al., 2025, Effect of Submaximal Doses of Semaglutide in Patients with Obesity Hey Mike- waiting for the have you or a loved one been injured by a GLP1. You do know that its coming right
K.BozikM